Clinicopathological Characteristics and Outcomes of Diffuse Crescentic Glomerulonephritis - A Single Center Experience from Southern India.

Introduction Diffuse Crescentic glomerulonephritis (CrGN) is characterized by rapidly progressive renal failure and has grave prognosis. There is significant regional and temporal variation in aetiology, prevalence and prognosis of diffuse crescentic glomerulonephritis (CrGN) with limited data available in adult Indian population. Aim This study aims to identify the aetiology, clinico-pathological features and outcomes of diffuse CrGN in south Indian population. Materials and Methods In this retrospective study, clinical records of all adults (>18 years) over a 5-year period (2010-2014) with a histopathological diagnosis of diffuse CrGN (>50% crescents) were reviewed. Clinical, serological, biochemical and histopathological data were collected. Follow-up data at six months including renal outcome and mortality were studied. Data was analysed using SPSS version 15. Results There were 29 cases of diffuse CrGN accounting for an incidence of 2.9% among 1016 non-transplant kidney biopsies. The most common cause was pauci-immune crescentic GN. The median creatinine at admission was 7.2 mg/dl {(interquartile range (IR) 3.3 - 10.4)} and 75.9% of patients required haemodialysis at admission. Complete/partial recovery was seen in 34.5%. At the end of six months 31% were dialysis dependent and the mortality was 27.6%. On univariate analysis, the significant predictors of renal loss and mortality were oliguria (p=0.02), requirement of haemodialysis and serum creatinine (p=0.001) at admission (>5.5mg/dl) (p=0.003). Histopathological features did not influence the outcome in our study. Conclusion In our cohort, the most common cause for diffuse CrGN is pauci-immune CrGN. Diffuse CrGN carries a poor prognosis. Patients with pauci-immune and AntiGBM disease have worst prognosis compared to immune complex CrGN. The presence of oliguria, high serum creatinine and requirement of haemodialysis at admission are associated with poor outcomes.

[1]  P. Priyamvada,et al.  Clinical spectrum and outcomes of crescentic glomerulonephritis: A single center experience , 2016, Indian journal of nephrology.

[2]  R. Cianci,et al.  Clinical and Histological Outcome Predictors in Renal Limited Pauci-Immune Crescentic Glomerulonephritis: A Single Centre Experience , 2012, International journal of immunopathology and pharmacology.

[3]  K. Alsaad,et al.  Glomerulonephritis with crescents among adult Saudi patients outcome and its predictors , 2012, Clinical and Experimental Medicine.

[4]  S. Agarwal,et al.  Crescentic glomerulonephritis: a clinical and histomorphological analysis of 46 cases. , 2011, Indian journal of pathology & microbiology.

[5]  Min Chen,et al.  The Immunopathological Spectrum of Crescentic Glomerulonephritis: A Survey of 106 Patients in a Single Chinese Center , 2010, Nephron Clinical Practice.

[6]  C. Zeng,et al.  Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients. , 2003, Chinese medical journal.

[7]  J. Jennette Rapidly progressive crescentic glomerulonephritis. , 2003, Kidney international.

[8]  唐政,et al.  Clinical spectrum of diffuse crescentic glomerulonephritis in Chinese patients , 2003 .

[9]  W. Couser Rapidly progressive glomerulonephritis: classification, pathogenetic mechanisms, and therapy. , 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  J. Velosa,et al.  Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.